Cargando…
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy
BACKGROUND: FIGHTDIGO study has shown the feasibility of handgrip strength (HGS) measurements in 201 consecutive digestive cancer patients undergoing chemotherapy. OBJECTIVE: This study focuses on a secondary aim of FIGHTDIGO study: the relationship between muscle mass and HGS. DESIGN: Two consecuti...
Autores principales: | Moreau, Johanna, Ordan, Marie‐Amélie, Barbe, Coralie, Mazza, Camille, Perrier, Marine, Botsen, Damien, Brasseur, Mathilde, Portefaix, Christophe, Renard, Yohann, Tallière, Barbara, Bertin, Eric, Hoeffel, Christine, Bouché, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639177/ https://www.ncbi.nlm.nih.gov/pubmed/31115188 http://dx.doi.org/10.1002/cam4.2238 |
Ejemplares similares
-
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
por: Botsen, Damien, et al.
Publicado: (2018) -
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study
por: Lemoine, Amélie, et al.
Publicado: (2022) -
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX)
por: Martin, Pierre, et al.
Publicado: (2022) -
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
por: Le Bozec, Antoine, et al.
Publicado: (2023) -
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
por: Moryoussef, Frédérick, et al.
Publicado: (2015)